CMIC Holdings Co Ltd
Jonathan Franco, MS, serves as Associate Director of Business Development at CMIC Group since April 2025, demonstrating expertise in Small Molecules, Cell & Gene Therapies, Anti-body Drug Conjugates, Oligonucleotides, and Emerging Therapeutic Modalities within the Bio-analytical sector. Prior roles include Business Development Manager at WuXi AppTec and the Center for Breakthrough Medicines, where Jonathan facilitated partnerships with Bio-techs and Pharma while ensuring compliance with regulatory guidelines for drug development. Previous experience includes a Senior Scientific Account Manager position at Absorption Systems, where Jonathan managed extensive client accounts and successfully closed numerous proposals. Earlier in the career, positions as Quality Assurance Specialist at Bayer Pharmaceuticals and Brenntag Group contributed to quality assurance and laboratory management skills. Jonathan holds a Master’s degree in Pharmaceutical Business/Project Management from Drexel University and a Bachelor’s degree in Biochemistry from Albright College.
This person is not in any teams
This person is not in any offices
CMIC Holdings Co Ltd
CMIC HOLDINGS Co., Ltd. mainly provides pharmaceutical development support services. The Contract Research Organization (CRO) segment offers monitoring, data management, pharmaceutical consulting and nonclinical services. The Contract Manufacturing Organization (CMO) segment is engaged in the entrusted manufacture of drugs for pharmaceutical companies. The Contract Sales Organization (CSO) segment is engaged in the operation and marketing support for medicinal products. The Health Care segment conducts site support institute (SMO) business, and provides health care information services. The Intellectual Property Development (IPD) segment develops and sells diagnostic products and orphan drugs.